BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Whitlow E, Mustafa AS, Hanif SNM. An Overview of the Development of New Vaccines for Tuberculosis. Vaccines (Basel) 2020;8:E586. [PMID: 33027958 DOI: 10.3390/vaccines8040586] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Barua N, Buragohain AK. Therapeutic Potential of Curcumin as an Antimycobacterial Agent. Biomolecules 2021;11:1278. [PMID: 34572491 DOI: 10.3390/biom11091278] [Reference Citation Analysis]
2 Mirzaei R, Babakhani S, Ajorloo P, Ahmadi RH, Hosseini-Fard SR, Keyvani H, Ahmadyousefi Y, Teimoori A, Zamani F, Karampoor S, Yousefimashouf R. The emerging role of exosomal miRNAs as a diagnostic and therapeutic biomarker in Mycobacterium tuberculosis infection. Mol Med 2021;27:34. [PMID: 33794771 DOI: 10.1186/s10020-021-00296-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
3 Mustafa AS. Immunological Characterization of Proteins Expressed by Genes Located in Mycobacterium tuberculosis-Specific Genomic Regions Encoding the ESAT6-like Proteins. Vaccines (Basel) 2021;9:27. [PMID: 33430286 DOI: 10.3390/vaccines9010027] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Barman S, Soni D, Brook B, Nanishi E, Dowling DJ. Precision Vaccine Development: Cues From Natural Immunity. Front Immunol 2021;12:662218. [PMID: 35222350 DOI: 10.3389/fimmu.2021.662218] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Mustafa AS. Adjuvants and Antigen-Delivery Systems for Subunit Vaccines against Tuberculosis. Vaccines (Basel) 2021;9:972. [PMID: 34579209 DOI: 10.3390/vaccines9090972] [Reference Citation Analysis]
6 Karamalakova Y, Stefanov I, Georgieva E, Nikolova G. Pulmonary Protein Oxidation and Oxidative Stress Modulation by Lemna minor L. in Progressive Bleomycin-Induced Idiopathic Pulmonary Fibrosis. Antioxidants 2022;11:523. [DOI: 10.3390/antiox11030523] [Reference Citation Analysis]
7 Fan XY, Lowrie DB. Where are the RNA vaccines for TB? Emerg Microbes Infect 2021;10:1217-8. [PMID: 34036874 DOI: 10.1080/22221751.2021.1935328] [Reference Citation Analysis]
8 Tripp RA. Advances in Vaccine Development. Vaccines (Basel) 2021;9:1036. [PMID: 34579273 DOI: 10.3390/vaccines9091036] [Reference Citation Analysis]
9 Choi S, Choi HG, Back YW, Park HS, Lee KI, Gurmessa SK, Pham TA, Kim HJ. A Dendritic Cell-Activating Rv1876 Protein Elicits Mycobacterium Bovis BCG-Prime Effect via Th1-Immune Response. Biomolecules 2021;11:1306. [PMID: 34572519 DOI: 10.3390/biom11091306] [Reference Citation Analysis]
10 Larsen SE, Williams BD, Rais M, Coler RN, Baldwin SL. It Takes a Village: The Multifaceted Immune Response to Mycobacterium tuberculosis Infection and Vaccine-Induced Immunity. Front Immunol 2022;13:840225. [PMID: 35359957 DOI: 10.3389/fimmu.2022.840225] [Reference Citation Analysis]
11 Chen S, Quan DH, Wang XT, Sandford S, Kirman JR, Britton WJ, Rehm BHA. Particulate Mycobacterial Vaccines Induce Protective Immunity against Tuberculosis in Mice. Nanomaterials (Basel) 2021;11:2060. [PMID: 34443891 DOI: 10.3390/nano11082060] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Zare S, Kabiri M, Amini Y, Najafi A, Mohammadpour F, Ayati SH, Nikpoor AR, Tafaghodi M. Immunological Assessment of Chitosan or Trimethyl Chitosan-Coated PLGA Nanospheres Containing Fusion Antigen as the Novel Vaccine Candidates Against Tuberculosis. AAPS PharmSciTech 2021;23:15. [PMID: 34893923 DOI: 10.1208/s12249-021-02146-z] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Gill CM, Dolan L, Piggott LM, Mclaughlin AM. New developments in tuberculosis diagnosis and treatment. Breathe 2022;18:210149. [DOI: 10.1183/20734735.0149-2021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Mustafa AS. BCG as a Vector for Novel Recombinant Vaccines against Infectious Diseases and Cancers. Vaccines (Basel) 2020;8:E736. [PMID: 33291702 DOI: 10.3390/vaccines8040736] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]